CJC-1295 / Ipamorelin· 10mg
Pre-blended GHRH + GHRP. The cleanest endogenous GH pulse.
Individual
$89.10
label.overview
Pre-blended CJC-1295 (no DAC) and Ipamorelin. CJC drives the GHRH side; ipamorelin selectively triggers the ghrelin receptor without cortisol spillover.
The standard research blend for IGF-1 elevation without endocrine side effects. CJC-1295 no DAC is a tetrasubstituted GHRH analog with a ~30 minute half-life; ipamorelin is the most selective GHRP available, with no measurable rise in ACTH, cortisol, or prolactin.
Mechanism
GHRH analog + selective GHRP ghrelin agonist.
Researcher notes
- • 100 mcg + 100 mcg subcutaneous, fasted, 1–3× daily.
- • Pre-sleep dose commonly emphasized to preserve nocturnal GH pulse.
- • Cycle: 12 weeks on, 4 weeks off.
Mechanism
GHRH analog + selective GHRP ghrelin agonist.
Half-life
CJC ~30 min; Ipamorelin ~2 hours
Reconstitution
Add 2 mL bacteriostatic water to the 10 mg blend. Each 0.02 mL = 100/100 mcg.
Storage
Lyophilized: 2–8 °C. Reconstituted: 2–8 °C, use within 30 days.
Reconstitution & general research dosing
- Reconstitution
- 2 mL bacteriostatic water into the 10 mg blended vial → 5 mg/mL combined (each 0.1 mL ≈ 250 mcg of each peptide, i.e. 500 mcg total).
- Typical research dose
- Reference ~250 mcg of each peptide per administration (500 mcg total per dose).
- Frequency
- 1–2× daily, subcutaneous, fasted state — pre-sleep dose commonly emphasized.
- Vial duration
- A 10 mg blended vial covers ~20 days at 1 administration/day and ~10 days at 2 administrations/day — both inside the 30-day reconstituted-use window.
- Storage
- Refrigerate 2–8 °C; use within 30 days reconstituted.
- GHRH + GHRP stack — fasted 1–2 hr window often referenced to preserve GH-pulse amplitude.